Valaciclovir vs ganciclovir or valganciclovir
CMV disease · solid organ transplant recipients
Valaciclovir showed no clear difference in CMV disease compared with ganciclovir or valganciclovir (low certainty).
1 finding from 1 review
- Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients 2024 · Cochrane Headline outcomes onlyRR 0.55 [0.17, 1.74]4 studies · 331 participantsLow